 The purpose of this study is to determine the efficiency of Olmesartan medoxomile OLMETEC alone or in combination with hydrochlorothiazide OLMETEC PLUS in the reduction of arterial blood pressure in patients with light to moderate hypertension, and to evaluate the percentage of patients that reach treatment goals using this antihypertensive regimen. 